Thrombolytic treatment after acute ischemic stroke

Abstract

The article on ‘thrombolytic treatment after
acute ischemic stroke’ was very timely, and the observation
that those who were ambulating independently prior to admission seemed to have ‘poor discharge outcomes’ was astute,
to say the least. However, I would have liked to hear from the
authors of this article, something, that would give us direction on reducing such poor outcomes. Could these patients
who were described as ‘rapid resolution of symptoms or mild
stroke’ actually suffer from ‘crescendo TIAs’ or other forms
of TIAs while hospitalized or in rehabilitation? This second
question is that if the patient initially improves perhaps not
to baseline but with minimal deficits, and then suffers neurological worsening on day 2, should onset time be reset to the
worsening of deficits and considered for thrombolytic treatment?